These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. Bracken MB, Shepard MJ, Collins WF, Holford TR, Young W, Baskin DS, Eisenberg HM, Flamm E, Leo-Summers L, Maroon J. N Engl J Med; 1990 May 17; 322(20):1405-11. PubMed ID: 2278545 [Abstract] [Full Text] [Related]
11. Non-painful sensory phenomena after spinal cord injury. Siddall PJ, McClelland J. J Neurol Neurosurg Psychiatry; 1999 May 17; 66(5):617-22. PubMed ID: 10209173 [Abstract] [Full Text] [Related]
18. Residual spinothalamic tract pathways predict development of central pain after spinal cord injury. Wasner G, Lee BB, Engel S, McLachlan E. Brain; 2008 Sep 17; 131(Pt 9):2387-400. PubMed ID: 18669485 [Abstract] [Full Text] [Related]
19. (-)-Epigallocatechin-3-gallate (EGCG) modulates neurological function when intravenously infused in acute and, chronically injured spinal cord of adult rats. Renno WM, Al-Khaledi G, Mousa A, Karam SM, Abul H, Asfar S. Neuropharmacology; 2014 Feb 17; 77():100-19. PubMed ID: 24071567 [Abstract] [Full Text] [Related]
20. Oscillating field stimulation for complete spinal cord injury in humans: a phase 1 trial. Shapiro S, Borgens R, Pascuzzi R, Roos K, Groff M, Purvines S, Rodgers RB, Hagy S, Nelson P. J Neurosurg Spine; 2005 Jan 17; 2(1):3-10. PubMed ID: 15658119 [Abstract] [Full Text] [Related] Page: [Next] [New Search]